All
Aesica Appoints Commercial Managing Director
Aesica appoints Ian Muir to the newly created position of commercial managing director.
Sartorius Appoints New Head of Lab Products & Services Division
Sartorius appoints Michael Melingo to head marketing, sales, and services of the Lab Products & Services Division.
FDA Outlines Agenda for New Guidances in 2014
FDA plans to issue a number of new guidances in 2014 that will address drug development and manufacturing practices.
NIH, Biopharmaceutical Companies, Non-profits Work to Speed Validation of Disease Targets
NIH, 10 biopharmaceutical companies, and several nonprofit organizations form a partnership to develop new treatments earlier for Alzheimer's, type 2 diabetes, and autoimmune disorders.
Thermo Fisher Scientific Completes Acquisition of Life Technologies
Thermo Fisher Scientific outlines new business segments with acquisition of Life Technologies.
Edison Pharmaceuticals Enters Alliance with Dainippon Sumitomo Pharma
Edison and DSP partner to develop drugs targeting cellular energy metabolism.
ISPE CEO to Step Down at End of 2014
International Society for Pharmaceutical Engineering will continue strategic plan initiated by Nancy Berg; search begins for replacement.
EMD Millipore Expands its Emprove Raw Materials Portfolio
EMD Millipore's expands its Emprove raw materials portfolio to include 400 products.
PharmaCell to Purchase Cell Therapy Production Facility from TiGenix
PharmaCell enters an agreement purchase TiGenix therapy production facility.
How Will CMOs Provide Sufficient Capacity for Growing Biologics Demand?
With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.
EMA Releases Pharmacogenomics Guidance
EMA's guidance focuses on the use of pharmacogenomics to improve drug safety monitoring.
National Cancer Institute Announces Genetic Sequencing Trial
NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes.
Novozymes Biopharma's Technology Demonstrates Potential for Monthly Drug Dosing
Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.
FDA Prohibits Another Ranbaxy Facility from Producing Drugs for US Market
FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location
EMA Recommended 81 Medicines for Marketing Authorization in 2013
In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.
Shire Appoints Susan Kilsby as Its New Chairman Effective April 2014
Shire appoints Susan Kilsby as its New Chairman.
Teva to Expand Central Nervous System Portfolio with Acquisition of NuPathe
Teva announced an agreement to acquire NuPathe and its migraine treatment patch.
Sanofi and Fraunhofer Create Center to Accelerate Antibiotic Research
The Natural Product Center of Excellence seeks to identify novel active compounds for new antibiotics.
The Carlyle Group Agrees to Acquire Johnson & Johnson#39;s Ortho-Clinical Diagnostics Business
J&J's diagnostics business goes to global asset manager, The Carlyle Group.
Stevens Institute of Technology Opens Biotechnology and Drug–Discovery Laboratory
The Stevens Institute of Technology will open a new biotechnology laboratory in January 2014.
Agilent Technologies, Picometrics Technologies to Offer CE–LIF–MS Systems
Combined technologies from Agilent Technologies and Picometrics Technologies are designed for large–molecule analysis.
Novasep Appoints New President of Synthesis Business Unit
Novasep selects Thierry van Nieuwenhove as new president of the synthesis business unit.
Lonza Signs Agreement with Index Ventures for Biological Products
Lonza signs an agreement with Index Ventures for the development and manufacture of biologics for portfolio companies.
USP Inaugurates Expanded Shanghai Facility
USP opens expanded Shanghai facility to enhance quality standards for medicines and food ingredients.
CBR–SYNARC and BioClinica Merge And Appoint New Chairman
CCBR–SYNARC and BioClinica merge to create a provider of specialized outsourced clinical services.
Merck Recalls Cholesterol Medicine Due to Packaging Defect
A packaging defect has led to Merck voluntarily recalling all lots of Liptruzet tablets in the United States.
USP Announces Revision Timeline, Effective Date for Elemental Impurities Limits and Procedures
USP announced the approval of General Notices section 5.60.30 Elemental Impurities in USP Drug Products and Dietary Supplements with an official date of Dec. 1, 2015.
CytomX Therapeutics and ImmunoGen to Develop Probody-Drug Conjugates
CytomX Therapeutics and ImmunoGen announce collaboration to develop probody-drug conjugate therapies for the treatment of cancer.
Eurofins Acquires the Discovery and Development Solutions Business of Merck KGaA
Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.
MedImmune Signs Cancer Pact with Immunocore
MedImmune has entered into a research collaboration with Immunocore to develop novel cancer therapies.
